Mark Harris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mark Harris has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Sachin Modi
University Hospital Southampton
4 shared publications - Timothy Bryant
Department of Interventional Radiology, University Hospital Southampton, Southampton, UK
4 shared publications - Nigel Hacking
Department of Interventional Radiology, University Hospital Southampton, Southampton, UK
3 shared publications - Drew Maclean
Department of Interventional Radiology, University Hospital Southampton, Southampton, UK
2 shared publications - Drew Maclean
Department of Interventional Radiology, University Hospital Southampton, Southampton, UK
2 shared publications - Ganesh Vigneswaran
University of Southampton, United Kingdom
2 shared publications
Latest Publications
- 25 January 2023
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 46 (4) , 528-531
Mid-term Results of the Prospective LUMI-PAE Study: Propensity-Matched Analysis of 1-Year Follow-Up Data
- 25 January 2023
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 46 (4) , 528-531
Mid-term Results of the Prospective LUMI-PAE Study: Propensity-Matched Analysis of 1-Year Follow-Up Data
- Open Access
- 6 April 2021
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 44 (7) , 1095-1102
Prostatic Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) have a Differential Impact on Lower Urinary Tract Symptoms (LUTS): Retrospective Analysis of the Multicentre UK-ROPE (UK Register of Prostate Embolization) Study
Purpose: To compare the relative IPSS (International Prostate Symptom Score) improvement in storage and voiding symptoms between prostatic artery embolization (PAE) and transurethral resection of the prostate (TURP). Method: Retrospective analysis of the UK-ROPE (UK Register of Prostate Embolization) multicentre database was conducted with inclusion of all patients with full IPSS questionnaire score data. The voiding and storage subscore improvement was compared between interventions. Student’s t-test (paired and unpaired) and ANOVA (Analysis of variance) were used to identify significant differences between the groups. Results: 146 patients (121 PAE, 25 TURP) were included in the analysis. Storage symptoms were more frequently the most severe symptom (‘storage’ in 75 patients vs ‘voiding’ in 17 patients). Between groups, no significant difference was seen in raw storage subscore improvement (TURP 4.9 vs PAE 4.2; p = 0.34) or voiding subscore improvement (TURP 8.4 vs PAE 6.7; p = 0.1). ANOVA demonstrated a greater proportionate reduction (relative to total IPSS) towards voiding symptoms in the TURP group (27.3% TURP vs 9.9% PAE, p = 0.001). Conclusion: Although both TURP and PAE improve voiding symptoms more than storage, a significantly larger proportion of total symptom reduction is due to voiding in the TURP cohort, with PAE providing a more balanced improvement between voiding and storage.
- 6 April 2021
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 44 (7) , 1095-1102
Open AccessProstatic Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) have a Differential Impact on Lower Urinary Tract Symptoms (LUTS): Retrospective Analysis of the Multicentre UK-ROPE (UK Register of Prostate Embolization) Study
Purpose: To compare the relative IPSS (International Prostate Symptom Score) improvement in storage and voiding symptoms between prostatic artery embolization (PAE) and transurethral resection of the prostate (TURP). Method: Retrospective analysis of the UK-ROPE (UK Register of Prostate Embolization) multicentre database was conducted with inclusion of all patients with full IPSS questionnaire score data. The voiding and storage subscore improvement was compared between interventions. Student’s t-test (paired and unpaired) and ANOVA (Analysis of variance) were used to identify significant differences between the groups. Results: 146 patients (121 PAE, 25 TURP) were included in the analysis. Storage symptoms were more frequently the most severe symptom (‘storage’ in 75 patients vs ‘voiding’ in 17 patients). Between groups, no significant difference was seen in raw storage subscore improvement (TURP 4.9 vs PAE 4.2; p = 0.34) or voiding subscore improvement (TURP 8.4 vs PAE 6.7; p = 0.1). ANOVA demonstrated a greater proportionate reduction (relative to total IPSS) towards voiding symptoms in the TURP group (27.3% TURP vs 9.9% PAE, p = 0.001). Conclusion: Although both TURP and PAE improve voiding symptoms more than storage, a significantly larger proportion of total symptom reduction is due to voiding in the TURP cohort, with PAE providing a more balanced improvement between voiding and storage.
- 3 December 2019
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 43 (3) , 459-465
The First 48 Consecutive Patients with 3-Year Symptom Score Follow-Up Post-Prostate Artery Embolization (PAE) at a Single-Centre University Hospital
Few studies on prostate artery embolization (PAE) follow patients up after 12 months. We aimed to evaluate the symptomatic efficacy of PAE in our patient cohort at 3 years.
- 3 December 2019
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 43 (3) , 459-465
The First 48 Consecutive Patients with 3-Year Symptom Score Follow-Up Post-Prostate Artery Embolization (PAE) at a Single-Centre University Hospital
Few studies on prostate artery embolization (PAE) follow patients up after 12 months. We aimed to evaluate the symptomatic efficacy of PAE in our patient cohort at 3 years.
- Open Access
- 22 August 2019
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 43 (1) , 23-28
Does Prostate Artery Embolization (PAE) Improve Voiding Symptoms, Storage Symptoms, or Both?
Introduction Many studies have looked at global changes in the International Prostate Symptom Score (IPSS) following PAE; however, no studies have examined the breakdown between storage and voiding symptoms. We aimed to explore the extent to which PAE improves storage symptoms in relation to voiding symptoms. Method This single-center, prospective cohort study recruited consecutive patients undergoing PAE from June 2012 to June 2016. The IPSS breakdown was recorded pre-PAE, at 3 months and 12 months post-PAE. Planned statistical analysis included the paired t test. Results A total of 43 patients were recruited (mean age 64.72 ± 6.27, prostate volume 88.65 ± 37.23 cm3, IPSS 23.02 ± 5.84, QoL 4.98 ± 1.01, PSA 4.2 ± 2.8). Storage symptoms were more frequently the most severe symptom (58.1%). Voiding score (13.35–5.39, p < 0.001) and storage score (9.67–5.08, p < 0.001) both improved; however, voiding improved to a greater extent (1.9 vs. 1.5 mean per question, p = 0.023). PAE was most consistent when improving storage symptoms (‘Urgency’ improved in 86% patients, ‘Frequency’ and ‘Nocturia’ 77%). Conclusion Storage symptoms are a significant problem for patients with benign prostatic obstruction. PAE is an effective treatment for both storage and voiding symptoms. More research is needed to evaluate how this compares with surgical techniques.
- 22 August 2019
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 43 (1) , 23-28
Open AccessDoes Prostate Artery Embolization (PAE) Improve Voiding Symptoms, Storage Symptoms, or Both?
Introduction Many studies have looked at global changes in the International Prostate Symptom Score (IPSS) following PAE; however, no studies have examined the breakdown between storage and voiding symptoms. We aimed to explore the extent to which PAE improves storage symptoms in relation to voiding symptoms. Method This single-center, prospective cohort study recruited consecutive patients undergoing PAE from June 2012 to June 2016. The IPSS breakdown was recorded pre-PAE, at 3 months and 12 months post-PAE. Planned statistical analysis included the paired t test. Results A total of 43 patients were recruited (mean age 64.72 ± 6.27, prostate volume 88.65 ± 37.23 cm3, IPSS 23.02 ± 5.84, QoL 4.98 ± 1.01, PSA 4.2 ± 2.8). Storage symptoms were more frequently the most severe symptom (58.1%). Voiding score (13.35–5.39, p < 0.001) and storage score (9.67–5.08, p < 0.001) both improved; however, voiding improved to a greater extent (1.9 vs. 1.5 mean per question, p = 0.023). PAE was most consistent when improving storage symptoms (‘Urgency’ improved in 86% patients, ‘Frequency’ and ‘Nocturia’ 77%). Conclusion Storage symptoms are a significant problem for patients with benign prostatic obstruction. PAE is an effective treatment for both storage and voiding symptoms. More research is needed to evaluate how this compares with surgical techniques.